Empowering Cessation ACS South Region
- Conditions
- Smoking Cessation
- Registration Number
- NCT06820034
- Lead Sponsor
- University of Oklahoma
- Brief Summary
Sexual and/or gender minority (SGM) people face a disproportionate burden of cancer risk, and tobacco use is a key modifiable risk factor. SGM tobacco-related disparities are especially pronounced in places with high levels of stigma against SGM people. This community-engaged and remotely-delivered Research Scholar Grant project will evaluate an empowerment-based smoking cessation intervention tailored for SGM people in high-stigma places. In partnership with Freedom Oklahoma (OK) and a Community Advisory Board from Arkansas (AR) and Texas (TX) this projects aims to: (1) Adapt SGM-serving volunteer activities from the Oklahoma intervention pilot study for delivery in nearby states; (2) Test intervention efficacy among SGM adults in OK, AR, and TX; (3) Identify treatment mechanisms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 400
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Biochemically-verified 7-day Point Prevalence Abstinence (PPA) at 26 weeks 26 weeks post-quit-date Self-reported smoking cessation abstinence will be biochemically verified with the iCOQuit Smokerlyzer expired carbon monoxide device 26 weeks after the participant's quit smoking date.
- Secondary Outcome Measures
Name Time Method Self-efficacy Week 0, Week 12, Week 26 -Self-Efficacy Scale/Confidence (SESC) Scale of 10 Very confident to 1 not at all confident. Higher score = greater self-efficacy to quit smoking
Motivation to quit smoking Week 0, Week 12, Week 26 -Motivation to change (Stages of Change \[SoC\] scale) 0 (Not at all ready)-----------------------10 (Extremely ready/already quit) Higher score = more motivation to quit smoking
Internalized transphobia Week 0; Week 12 Gender Minority Stress and Resilience: Internalized transphobia subscale 5-point Likert scale; Strongly disagree to Strongly agree Higher score = greater internalized transphobia
Prosociality Week 0; Week 12 Well-Being in Prosociality \[Chi K, Almeida DM, Charles ST, et al. Daily prosocial activities and well-being: Age moderation in two national studies. Psychology and Aging 2021;36(1):83.\] 5-point Likert Scale: Strongly agree to Strongly disagree Higher score indicates greater prosociality
Nicotine Replacement Therapy (NRT) Adherence Weeks 1, 3, 5, 7, 9, 11 Medication Adherence Questionnaire (MAQ) Yes=0; No=1; higher score = greater adherence
Sexual Orientation Identity Pride Week 0, Week 12 Lesbian, Gay, and Bisexual Identity Scales: Identity Concealment Motivation subscale; Internalized Homonegativity; Identity Acceptance Concerns 6-point scale: 1=Disagree strongly... 6=Strongly agree Higher score = greater identity concerns
Adaptive coping with minority stress Week 0; Week 12 Brief- Coping Orientation to Problems Experienced Inventory (COPE) \[adapted\]
5-point Likert scale; Strongly disagree to Strongly agree. Higher score = more copingSocial Support Week 0; Week 12 Patient-Reported Outcomes Measurement Information System (PROMIS) emotional support scale.
5-point Likert scale; Strongly disagree = least support ... Strongly agree = most supportSmoking intensity Week 0, Week 12, Week 26 -Smoking intensity will be assessed by past-week smoking days and past-week cigarettes per smoking day.
Greater number of smoking days and great number of cigarettes per day = greater smoking intensitySmoking cessation app engagement Weeks 3, 5, 7, 9, 11 Self-report of number of times per day participant opened app, on average, over the past week. Greater number of times opened = greater engagement
Gender identity and expression pride Week 0, Week 12 Gender Minority Stress and Resilience: Gender Identity \& Expression Pride subscale 5-point Likert scale; Strongly disagree to Strongly agree Higher score = greater gender identity and expression pride
Intervention satisfaction Weeks 3, 5, 7, 9, 12 Validated measures of intervention feasibility, acceptability, and appropriateness (Weiner et al, 2017) 5 point ordinal scale from "completely disagree=0" to "completely agree=4"; higher score = greater intervention satisfaction
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.